http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021195360-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fb9f44db08d1c42a53f3d28eaae416f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-86
filingDate 2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f130a35efef58fe7ae881e139da81a2
publicationDate 2021-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021195360-A
titleOfInvention Oral composition
abstract PROBLEM TO BE SOLVED: To provide an oral composition capable of sufficiently exerting an effect of suppressing plaque formation by glycyrrhetinic acid while containing an anionic surfactant and / or a nonionic surfactant as a surfactant. The following components (A) to (D): (A) Glycyrrhetinic acid 0.006% by mass or more and 0.5% by mass or less (B) One or more polymer compounds selected from arginate, carrageenan and carboxymethyl cellulose or salts thereof (C) Anionic surfactant One or more surfactants selected from (c1) and nonionic surfactant (c2) (D) Contains one or more solvents selected from propylene glycol, ethanol and polyethylene glycol. An oral composition having a mass ratio ((A) / (B)) of the content of the component (A) to the content of the component (B) of 0.0005 or more and 40 or less. [Selection diagram] None
priorityDate 2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61152622-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6335515-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006206581-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012144490-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63162617-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450282151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425978919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3318739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425035971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3938668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11966249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426185960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5121662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426058410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410901954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408839960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10114

Total number of triples: 46.